These results suggest that A549/DDP, PC9-GR, and PC9-Nanog+ cell lines display both multiple drug resistance and CSC-like properties, making them suitable for investigating the drug resistance mechanism in NSCLC. The gene discussed is NANOG; the disease is non-small cell lung carcinoma.